`571.272.7822
`
`
`
` Paper No. 15
`
` Entered: November 8, 2018
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`MONAGHAN MEDICAL CORP.,
`Petitioner,
`
`v.
`
`SMITHS MEDICAL ASD, INC.,
`Patent Owner.
`____________
`
`IPR2018-01466, Patent 7,059,324 B2
`IPR2018-01481, Patent 6,581,598 B1
`____________
`
`
`
`Before SCOTT A. DANIELS, TIMOTHY J. GOODSON, and
`ALYSSA A. FINAMORE, Administrative Patent Judges.
`
`FINAMORE, Administrative Patent Judge.
`
`
`
`
`ORDER
`Granting Joint Motion to Terminate Proceeding Due to
`Settlement before Institution Decision and
`Granting Joint Request to File Settlement Agreement as
`Business Confidential Information
`37 C.F.R. § 42.74
`
`
`
`
`
`
`
`IPR2018-01466, Patent 7,059,324 B2
`IPR2018-01481, Patent 6,581,598 B1
`
`
`INTRODUCTION
`I.
`In each of the above-referenced inter partes review proceedings,
`Petitioner and Patent Owner jointly request that the respective proceeding be
`terminated pursuant to a settlement. On October 24, 2018, with our
`authorization, the parties filed a Joint Motion to Terminate Proceeding
`(Paper 13, “Joint Motion”), a copy of a Confidential Settlement Agreement
`(Ex. 1019, “Settlement Agreement”), and a Joint Request to File Settlement
`Agreement as Business Confidential Information (Paper 14, “Joint
`Request”). 1
`
`
`II. DISCUSSION
`In the Joint Motion, the parties represent that they have reached an
`agreement to jointly request termination of the inter partes review
`proceeding, and that the filed copy of the Settlement Agreement is a true and
`correct copy. Joint Mot. 1–2. 2 The parties further represent that their
`Settlement Agreement resolves the related district court litigation, as well as
`the related inter partes review proceeding, IPR2018-01481. Id. at 1.
`Each of these proceedings is at an early stage, and we have not yet
`decided whether to institute an inter partes review in either proceeding. In
`view of the early stage of the proceedings and the settlement between the
`parties, we determine that good cause exists to terminate the proceedings.
`
`
`1 The parties filed similar papers in both proceedings. We cite to
`IPR2018-01466 as exemplary.
`2 The Joint Motion does not include page numbers. We refer to the pages of
`the Joint Motion as consecutively numbered, beginning with the page
`following the cover page as page 1.
`
`2
`
`
`
`IPR2018-01466, Patent 7,059,324 B2
`IPR2018-01481, Patent 6,581,598 B1
`
`
`With respect to the parties’ Joint Request, we have reviewed the
`Settlement Agreement and find that the Settlement Agreement contains
`confidential business information regarding the terms of settlement. We
`determine that good cause exists to treat the Settlement Agreement as
`business confidential information pursuant to 37 C.F.R. § 42.74(c).
`
`
`III. CONCLUSION
`For the foregoing reasons, we grant the parties’ Joint Motion and Joint
`Request in each proceeding. This determination does not constitute a final
`written decision pursuant to 35 U.S.C. § 318(a).
`
`
`IV. ORDER
`
`Accordingly, it is:
`ORDERED that the Joint Motion to Terminate in each proceeding is
`granted, and IPR2018-01466 and IPR2018-01481 are terminated;
`
`FURTHER ORDERED that the Joint Request to File the Settlement
`Agreement as Business Confidential Information in each proceeding is
`granted, and the Settlement Agreement in each proceeding shall be kept
`separate from the respective file of U.S. Patent No. 7,059,324 B2 and U.S.
`Patent No. 6,581,598 B1, and made available only to Federal Government
`agencies on written request, or to any person on a showing of good cause,
`pursuant to 37 C.F.R. § 42.74(c).
`
`
`
`
`
`
`
`
`
`3
`
`
`
`IPR2018-01466, Patent 7,059,324 B2
`IPR2018-01481, Patent 6,581,598 B1
`
`For PETITIONER:
`David Linder
`dlinder@brinksgilson.com
`
`William Frankel
`wfrankel@brinksgilson.com
`
`For PATENT OWNER:
`Jeremy D. Peterson
`jeremy.peterson@morganlewis.com
`
`John D. Zele
`john.zele@morganlewis.com
`
`
`
`
`
`4
`
`